The global Biopharmaceuticals Contract Manufacturing Service market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The United States Biopharmaceuticals Contract Manufacturing Service market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Biopharmaceuticals Contract Manufacturing Service Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
United States Biopharmaceuticals Contract Manufacturing Service Market, By Type, 2016-2021, 2022-2027 ($ Millions)
United States Biopharmaceuticals Contract Manufacturing Service Market Segment Percentages, By Type, 2020 (%)
Process Development
Manufacturing
Packaging

United States Biopharmaceuticals Contract Manufacturing Service Market, By Application, 2016-2021, 2022-2027 ($ Millions)
United States Biopharmaceuticals Contract Manufacturing Service Market Segment Percentages, By Application, 2020 (%)
Peptides and Protein
Antibodies
Vaccines
Biosimilars
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biopharmaceuticals Contract Manufacturing Service revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Biopharmaceuticals Contract Manufacturing Service revenues share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Lonza Group
Rentschler Biotechnologie
JRS Pharma
Samsung BioLogics
WuXi Biologics
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Pfizer
Roche
Johnson & Johnson
Merck
Sanofi
AbbVie
GlaxoSmithKline
Takeda
Galentic Pharma
Novo Medi Sciences